GoPath Diagnostics invites you to join us at booth 17155 at the 2025 ASCO Annual Meeting, where we will be showcasing how our OncoTarget Series uses genomic profiling to help guide therapy selection in advanced solid tumors and leukemias.

Our team is eager to engage with you on how our cutting-edge services can enhance patient care and support your clinical decisions.